Laughable Liminal
from their about us web page...
Strategy:
To build our portfolio of small molecule anti-fibrotic therapeutics through the development of multiple compounds in specific indications in respiratory, liver and kidney diseases.
from their managment team web page...
no science officer, nothing whatsoever related to development lol
What a laugh ....